AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
Form_NN
20-F_NN
Information_NOMZ
2003_CD
87_CD
22_CD
Net_JJ
cash_NN
inflow_NN
from_PIN
trading_GER
operations_NOMZ
2003 2002 2001_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Operating_GER
profit_NN
before_IN
exceptional_JJ
items_NN
4,111_CD
4,356_CD
4,156_CD
Depreciation_NOMZ
and_PHC
amortisation_NOMZ
1,290_CD
960_CD
860_CD
Stocks_NN
increase_NN
decrease_NN
131 101 417_CD
Debtors_NN
increase_NN
decrease_NN
540 198 138_CD
Creditors_NN
increase_NN
decrease_NN
430 402 727_CD
Other_JJ
non-cash_JJ
movements_NOMZ
317_CD
65_CD
120_CD
4,617_CD
5,686_CD
4,130_CD
23_CD
Cash_NN
flows_VPRT
related_VBN
to_PIN
exceptional_JJ
items_NN
Current_JJ
period_NN
cash_NN
flow_NN
related_VBN [WZPAST]
to_PIN
exceptional_JJ
items_NN
and_PHC
merger_NN
2003 2002 2001_CD
related_JJ
payments_NOMZ
,_,
before_IN
associated_VBN
tax_NN
charge_NN
relief_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
Synergy_NN
and_PHC
integration_NOMZ
costs_NN
25_CD
68_CD
312_CD
Zoladex_NN
OIG_NN
settlement_NOMZ
355_CD
Costs_NN
relating_VBG [WZPRES]
to_PIN
disposals_NN
and_PHC
demerger_NN
of_PIN
other_JJ
businesses_NOMZ
11_CD
25_CD
56_CD
Outflow_NN
related_VBN [WZPAST]
to_PIN
exceptional_JJ
items_NN
391_CD
93_CD
368_CD
Proceeds_NN
from_PIN
disposal_NN
of_PIN
fixed_JJ
assets_NN
accounted_VBD
for_PIN
as_IN
exceptional_JJ
10_CD
Exceptional_JJ
items_NN
cash_NN
flow_NN
391_CD
93_CD
358_CD
24_CD
Acquisitions_NOMZ
of_PIN
subsidiaries_NN
and_PHC
purchases_NN
of_PIN
minority_NOMZ
interests_NN
There_EX
were_VBD
no_SYNE
significant_JJ
business_NOMZ
acquisitions_NOMZ
in_PIN
any_QUAN
of_PIN
the_DT
years_NN
presented_VBN
._.
All_QUAN
acquisitions_NOMZ
have_VPRT [PEAS]
been_VBN [PASS]
accounted_VBN
for_PIN
by_PIN
the_DT
purchase_NN
method_NN
of_PIN
accounting_GER
._.
2003 2002 2001_CD
Total_JJ
Total_JJ
Total_JJ
fair_JJ
fair_JJ
fair_JJ
value_NN
value_NN
value_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD [PASS]
Fixed_VBN
assets_NN
4_CD
Current_JJ
assets_NN
26_CD
Creditors_NN
due_JJ
within_PIN
one_CD
year_NN
16_CD
Provisions_NN
for_PIN
liabilities_NOMZ
and_PHC
charges_NN
1_CD
Fair_NN
value_NN
of_PIN
net_JJ
assets_NN
acquired_VBN
13_CD
Goodwill_NN
acquired_VBD
41_CD
Consideration_NOMZ
for_PIN
subsidiaries_NN
and_PHC
operations_NOMZ
acquired_VBD
54_CD
Purchases_NN
of_PIN
minority_NOMZ
interests_NN
7_CD
47_CD
Less_RB
:_:
Cash_NN
included_VBD
in_PIN
undertaking_VBG
acquired_VBN
3_CD
Net_JJ
cash_NN
consideration_NOMZ
44_CD
Assets_NN
and_PHC
liabilities_NOMZ
were_VBD [PASS]
adjusted_VBN
to_PIN
their_TPP3
fair_JJ
values_NN
based_VBN [WZPAST]
on_PIN
external_JJ
valuations_NOMZ
and_CC
internal_JJ
assessments_NOMZ
._.
There_EX
were_VBD
no_SYNE
significant_JJ
differences_NN
between_PIN
book_NN
and_CC
fair_JJ
values_NN
in_PIN
respect_NN
of_PIN
the_DT
acquisitions_NOMZ
made_VBN
._.
